Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Add To Watchlist

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Trevor Rose's Insights - DON'T BUY

View:

Post by Possibleidiot01 on May 13, 2024 11:04pm

Trevor Rose's Insights - DON'T BUY

DON'T BUY

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

The stock is acting better, and is up 15% YTD. It has been a while since it saw $6. EPS was -4c vs expectations of (nil). Revenue was $86.6M, beating estimates of $83.1M. EBITDA of $13.58M missed estimates of this $14.47M. Guidance was largely maintained. Revenue rose 4.9%, with margins a bit higher than estimates. Net cash is about $90M. Still not much excitement here. Some recent partnerships look more interesting than the quarterly results. It is good to see the sales gain, but we would not yet call this a dramatic turn.
Unlock Premium - Try 5i Free

$6.050